COMMENTARY   Open Access    

Quizartinib is a good option for AML patients with FLT3-ITD mutations

    Show all affliationsShow less
More Information
  • 加载中
  • [1] Xuan, L., Wang, Y., Huang, F., et al. (2020). Sorafenib maintenance in patients with FLT3-ITD acute myeloid leukaemia undergoing allogeneic haematopoietic stem-cell transplantation: an open-label, multicentre, randomised phase 3 trial. Lancet Oncol 21, 1201−1212.

    View in Article CrossRef Google Scholar

    [2] Stone, R.M., Mandrekar, S.J., Sanford, B.L., et al. (2017). Midostaurin plus Chemotherapy for Acute Myeloid Leukemia with a FLT3 Mutation. N Engl J Med 377, 454−464.

    View in Article CrossRef Google Scholar

    [3] Erba, H.P., Montesinos, P., Kim, H.J., et al. (2023). Quizartinib plus chemotherapy in newly diagnosed patients with FLT3-internal-tandem-duplication-positive acute myeloid leukaemia (QuANTUM-First): a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet (London, England) 401, 1571−1583.

    View in Article CrossRef Google Scholar

    [4] Dohner, H., Wei, A.H., Appelbaum, F.R., et al. (2022). Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN. Blood 140, 1345−1377.

    View in Article CrossRef Google Scholar

    [5] Daver, N., Perl, A.E., Maly, J., et al. (2022). Venetoclax Plus Gilteritinib for FLT3-Mutated Relapsed/Refractory Acute Myeloid Leukemia. J Clin Oncol 40, 4048−4059.

    View in Article Google Scholar

  • Cite this article:

    Cao Y., Zhang C., Cao L., et al., (2023). Quizartinib is a good option for AML patients with FLT3-ITD mutations. The Innovation Medicine 1(1), 100007. https://doi.org/10.59717/j.xinn-med.2023.100007
    Cao Y., Zhang C., Cao L., et al., (2023). Quizartinib is a good option for AML patients with FLT3-ITD mutations. The Innovation Medicine 1(1), 100007. https://doi.org/10.59717/j.xinn-med.2023.100007

Figures(1)    

Share

  • Share the QR code with wechat scanning code to friends and circle of friends.

Article Metrics

Article views(2078) PDF downloads(416) Cited by(0)

Relative Articles

Article Contents

Catalog

    /

    DownLoad:  Full-Size Img  PowerPoint